3 | SEC Filings Hub

Filing metadata

Accession number: 0001140361-21-023005
Form type: Form 3
Filer: Ernexa Therapeutics Inc.
CIK: CIK 748592
Filed: Jun 30, 2021
Reporting period: Jun 28, 2021
Description: Initial ownership

Documents

0001140361-21-023005-index.htm

Complete submission

0001140361-21-023005.txt

directory listing

Filed by

Ernexa Therapeutics Inc.